文献速递中医内科中药与中成药合理使用

连花清瘟治疗COVID-19的网络药理学机制分析

Network pharmacology analysis of the therapeutic mechanisms of the traditional Chinese herbal formula Lian Hua Qing Wen in Corona virus disease 2019 (COVID-19), gives fundamental support to the clinical use of LHQW.
PubMed 文献 · Phytomedicine · 2020-09-06

LHQW与ACE2共表达蛋白共享189个蛋白,提示其通过调节炎症、抗病毒、修复肺损伤及缓解细胞因子风暴发挥作用。

要点

  • 连花清瘟13味药中10味归肺经,支持其在肺系疾病中的特异性作用。
  • 核心网络含2480个靶点、160266个蛋白互作,具无标度属性。
  • 6个功能模块富集于白细胞介导免疫、干扰素γ信号等通路。

核心结论

  • 连花清瘟通过调节炎症过程、发挥抗病毒效应、修复肺损伤、缓解细胞因子风暴及改善ACE2表达紊乱相关症状来治疗COVID-19。

研究设计与样本

  • 基于连花清瘟组方归经信息与成分靶点蛋白互作(PPI)数据,构建中药-归经网络与蛋白互作网络(PIN)。
  • 采用Hub与拓扑属性分析获取关键靶点并构建核心LHQW-PIN,使用MCODE确定功能模块,并进行GO与KEGG通路富集分析。
  • 计算LHQW相关蛋白与ACE2共表达蛋白的交集。

主要发现

  • 连花清瘟13味药中10味与肺系统相关,其余与胃、心、肝、脾系统相关。
  • 6个模块富集于白细胞介导免疫、干扰素γ介导信号通路、免疫应答调节信号通路、白介素23介导信号通路及Fcγ受体介导吞噬作用(GO分析)。
  • 上述6个模块亦富集于癌症、免疫系统疾病及病毒感染性疾病(KEGG分析)。
  • LHQW与ACE2共表达蛋白共享189个蛋白。

临床怎么用

  • 网络药理学证据提示连花清瘟对COVID-19的多靶点作用机制,支持其临床用于COVID-19治疗。
  • 归经分析显示连花清瘟主要归肺经,可解释其在肺系疾病中的应用。
  • 涉及免疫调节与抗病毒通路的结果为连花清瘟治疗其他相关疾病提供了药理学依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The traditional Chinese Medicine (TCM) herbal formula Lian Hua Qing Wen (LHQW) improves the results of COVID-19 treatment. Three very recent studies analyzed with network pharmacology some working mechanisms of LHQW. However, we used more techniques and also included Angiotensin converting enzyme 2 (ACE2) (a SARS-CoV receptor, possibly the viral entry point in alveolar lung cells) and the immune system, as cytokine storm is essential in the late phase. PURPOSE: Extensive detailed Network Pharmacology analysis of the LHQW- treatment mechanism in COVID-19. METHODS: TCM-herb-meridian and protein interaction network (PIN) of LHQW, based on LHQW herbs meridian information and the protein-protein interaction (PPI) information of the LHQW-component targets. Hub and topological property analyses to obtain crucial targets and construct the crucial LHQW-PIN. Functional modules determination using MCODE, GO and KEGG pathway analysis of biological processes and pathway enrichment. Intersection calculations between the LHQW-proteins and ACE2 co-expression-proteins. RESULTS: LHQW herbs have relationships to Stomach-, Heart-, Liver- and Spleen-systems, but most (10 of the 13 herbs) to the Lung system, indicating specific effects in lung diseases. The crucial LHQW PIN has the scale-free property, contains 2,480 targets, 160,266 PPIs and thirty functional modules. Six modules are enriched in leukocyte-mediated immunity, the interferon-gamma-mediated signaling pathway, immune response regulating signaling pathway, interleukin 23 mediated signaling pathway and Fc gamma receptor-mediated phagocytosis (GO analysis). These 6 are also enriched in cancer, immune system-, and viral infection diseases (KEGG). LHQW shared 189 proteins with ACE2 co-expression proteins. CONCLUSIONS: Detailed network analysis shows, that LHQW herbal TCM treatment modulates the inflammatory process, exerts antiviral effects and repairs lung injury. Moreover, it also relieves the "cytokine storm" and improves ACE2-expression-disorder-caused symptoms. These innovative findings give a rational pharmacological basis and support for treating COVID-19 and possibly other diseases with LHQW.

来源:Phytomedicine,查看原文。版权归原作者所有。

引用

  1. Zheng S, Baak JP, Li S, et al. Network pharmacology analysis of the therapeutic mechanisms of the traditional Chinese herbal formula Lian Hua Qing Wen in Corona virus disease 2019 (COVID-19), gives fundamental support to the clinical use of LHQW. Phytomedicine. 2020. PMID: 32949888. doi:10.1016/j.phymed.2020.153336

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。